ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Endovascular

November 21, 2023
Carotid-axillary bypass is a safe and effective alternative for subclavian revascularization that is easy for cardiac surgeons.
November 15, 2023
A review of voluntary international multi-registry data on salvage of failed catheter insertion of stent grafts for aortic aneurysms
September 15, 2023
A new device developed by researchers at University of Central Florida and Orlando Health monitors blood in real time to provide surgeons with analysis and track for deadly blood coagulation. Monitoring for this complication is especially important in cardiac surgery on infants, who cannot consistently have their blood drawn for testing.
August 31, 2023
An open access genomic study of carotid atheroma : when should we offer revascularisation?
April 26, 2023
On April 21, Dr. Randy Moore at the University of Calgary in Canada performed the first implantation of Terumo's new hybrid graft, Thoracoflo, in North America for thoracoabdominal aortic aneurysm repair.
November 14, 2022
Quite possibly, this manuscript is projected to have the highest impact on patient care and industry for the immediate future.
November 3, 2022
On November 2, 2022, the American College of Cardiology (ACC) and American Heart Association (AHA) published an update to the 2010 ACC/AHA Guidelines for the Diagnosis and Management of Aortic Disease. The top ten take-home messages are:
September 9, 2022
The authors of this study reported the safety and one-year clinical outcomes of the Thoraflex Hybrid frozen elephant trunk prosthesis from the US Investigational Device Exemption trial.  Follow-up was available in 63 of 65 patients from twelve centers at one-year, when the mortality was 11 percent (7/65), and freedom was 81 percent (51/63) from major
July 1, 2022
This is an interesting, well-written account of pooled results of two medium-size RCTs . It would be interesting to see a third arm of optimum medical therapy in follow-up studies ...
May 20, 2022
This is a compreshensive review on the experience with use of TEVAR in patients with Marfan syndrome, including durablity, complications, and timing, etc.  Drs. Steinmetz and Cosellihe also discussed the role and trend of TEVAR in Marfan paitents with aortic disease.

Pages